Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-02-20 @ 12:46 PM
Study NCT ID:
NCT02760602
Status:
TERMINATED
Last Update Posted:
2019-10-10
First Post:
2016-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
16349
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None